Literature DB >> 14671208

Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome.

Catherine J Owen1, Claire E Jennings, Helen Imrie, Alain Lachaux, Nicola A Bridges, Tim D Cheetham, Simon H S Pearce.   

Abstract

The immunodysregulation, polyendocrinopathy, enteropathy syndrome (IPEX), is a rare disorder of immune regulation resulting in multiple autoimmune disorders, which demonstrates X-linked recessive inheritance. The disease gene, FOXP3, was identified in 2001, and several mutations within this gene have since been described in patients with IPEX. We used linkage analysis, mutational screening of the FOXP3 gene, human leukocyte antigen typing, and analysis of X-chromosome inactivation to investigate 2 kindreds (21 subjects in total) with 4 male infants (3 now deceased) and 1 girl affected by IPEX. In 1 family a novel FOXP3 mutation was identified in the proband, with a single base deletion at codon 76 of exon 2, leading to a frameshift, which predicted a truncated protein product (108 residues vs. 431 in wild type). In the second family, the FOXP3 locus was excluded by recombination, and mutational analysis of the gene was negative. The affected girl from this family was shown to have human leukocyte antigen DR2 and DR6 alleles and random X-chromosome inactivation in peripheral blood mononuclear cells. Our analysis has elucidated the molecular basis of IPEX in one family and has, for the first time, provided evidence for an autosomal locus, suggesting genetic heterogeneity in this syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671208     DOI: 10.1210/jc.2003-031080

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.

Authors:  Ajay V Maker; Peter Attia; Steven A Rosenberg
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

2.  IPEX Syndrome, FOXP3 and Cancer.

Authors:  Runhua Liu; Silin Li; Wei-Hsiung Yang; Lizhong Wang
Journal:  J Syndr       Date:  2013-06

Review 3.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

Review 4.  Autoimmune Enteropathy: An Updated Review with Special Focus on Stem Cell Transplant Therapy.

Authors:  Zunirah Ahmed; Aamer Imdad; James A Connelly; Sari Acra
Journal:  Dig Dis Sci       Date:  2018-11-10       Impact factor: 3.199

5.  Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.

Authors:  Nihal Işik; Nüket Yildiz Manukyan; İlknur Aydin Cantürk; Fatma Candan; Ayşen Ünsal Çakmak; Güher Saru Han Direskeneli
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

6.  Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.

Authors:  Erika Smith; Siri Atma W Greeley; Honggang Ye; Troy R Torgerson; Reed Dimmitt; Prescott Atkinson; Joseph Philips; Frederick Goldman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

7.  Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

Authors:  D Zennaro; E Scala; D Pomponi; E Caprini; D Arcelli; E Gambineri; G Russo; A Mari
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

8.  Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Yuya Hashimura; Kandai Nozu; Hirokazu Kanegane; Toshio Miyawaki; Akira Hayakawa; Norishige Yoshikawa; Koichi Nakanishi; Minoru Takemoto; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

Review 9.  FOXP3: genetic and epigenetic implications for autoimmunity.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  J Autoimmun       Date:  2013-01-11       Impact factor: 7.094

Review 10.  Insights into type 1 diabetes from the autoimmune polyendocrine syndromes.

Authors:  Mickie H Cheng; Mark S Anderson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-08       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.